PCOS Patients Immune Status Evaluation
Conditions: Polycystic Ovary Syndrom; Metformin; Immune Function Interventions: Diagnostic Test: Detect the immune function of peripheral blood samples Sponsors: Shanghai 10th People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Correlating Improvement in PCOS Symptoms to the Percentage of Body Weight Lost in Females Also Living With Obesity
Conditions: Polycystic Ovary Syndrome; Obesity Interventions: Behavioral: STREAM program Sponsors: Ottawa Hospital Research Institute; LEAF Weight Loss Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting
Conditions: Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
PCOS Immune Function Predicts Metformin Efficacy
Conditions: Polycystic Ovary Syndrome; Metformin; Immune Function Interventions: Drug: Metformin Sponsors: Shanghai 10th People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Spatial Radiogenomics of Ovarian Cancer: Implementation of a Lesion-specific 3D-printed Mould Pipeline in the Clinical Workflow for Image-guided Tissue Multi-sampling of Ovarian Tumours
Conditions: Ovarian Cancer Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Conditions: Platinum-resistant Ovarian Cancer; Recurrent Ovary Cancer; Ovarian Cancer; Ovarian Carcinoma; Ovarian Carcinoma, Recurrent Interventions: Biological: Cytokine-Induced Memory-like Natural Killer Cells; Biological: IL-15 Superagonist Sponsors: Dana-Farber Cancer Institute; ImmunityBio, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
Conditions: Infertility Sponsors: Changchun GeneScience Pharmaceutical Co., Ltd.; Sixth Affiliated Hospital, Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression
Conditions: Ovarian Cancer Sponsors: Ain Shams University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids
Conditions: Ovarian Cancer Interventions: Other: growth prediction of ovarian cancer organoids in the frame of bright field image by leveraging AI Sponsors: Chongqing University Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
GREM1, HAS2 and PTGS2 Gene Expression Following the in Vitro Maturation (IVM)
Conditions: Increased Oocyte Death; in Vitro Maturation; GREM1 Gene Mutation; Cumulus Cell Interventions: Genetic: cumulus cell oocytes complex (COC) among women with poor ovarian reserve Sponsors: National University of Malaysia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer
Conditions: Epithelial Ovarian Cancer; Stage III Ovarian Cancer; Stage IV Ovarian Cancer Sponsors: The First Hospital of Jilin University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
Conditions: Platinum-resistant Ovarian Cancer; Refractory Ovarian Carcinoma Interventions: Drug: CBX-12 Sponsors: Cybrexa Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Conditions: Surgery Interventions: Behavioral: Educational Module; Procedure: Salpingectomy Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer
Conditions: Recurrent Ovarian Cancer Interventions: Drug: Bevacizumab ； HRS-1167 Sponsors: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
Conditions: Cancer; Solid Tumor; Colorectal Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Targeted Therapy; Chemotherapy; Immunotherapy; Precision Therapy Interventions: Genetic: SNP; Drug: Palbociclib 125mg; Drug: Bevacizumab Sponsors: Lebanese University; Haykel Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
